Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability

Author： Shipkova Maria Armstrong Victor William Oellerich Michael Wieland Eberhard

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.3, 2005-10, pp. : 505-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate mofetil in solid-organ transplantation

By Srinivas Titte R Kaplan Bruce Meier-Kriesche Herwig-Ulf

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2325-2345

Informa Healthcare

Access to resources Recommend Favorite

Mycophenolate Mofetil: A Pharmacoeconomic Review of its Use in Solid Organ Transplantation

By Young M. Plosker G.L.

PharmacoEconomics, Vol. 20, Iss. 10, 2002-01 ,pp. : 675-713

Adis International

Access to resources Recommend Favorite

The safety of mycophenolate mofetil in pregnancy

By Pisoni Cecilia N D'Cruz David P

Expert Opinion on Drug Safety, Vol. 7, Iss. 3, 2008-05 ,pp. : 219-222

Informa Healthcare

Access to resources Recommend Favorite

Immunosuppressants: Nephrogenic systemic fibrosis (first report with prednisone, tacrolimus and mycophenolate mofetil) after organ transplantation: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Enteric-Coated Mycophenolate Sodium: Tolerability Profile Compared with Mycophenolate Mofetil

By Behrend Matthias

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1037-1050

Adis International

Access to resources Recommend Favorite